Clindamycin Phosphate Injection — FDA Drug Shortage

Current — Pfizer Inc.

The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Pfizer Inc. with status Current. The shortage was first posted on Mar 21, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Pfizer Inc.
Package NDC
0009-0870-26
Dosage Form
Injection
Presentation
Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)
Initial Posting
Mar 21, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.